Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01066702 · ClinicalTrials.gov registry record · Phase 3
Confirmatory Study of NeoCart in Knee Cartilage Repair
A Phase 3 study, sponsored by Histogenics Corporation.
- Terminated
- Registry status
- Phase 3
- Development phase
- 245
- Enrollment target
NCT01066702: Clinical Trial Phase 3 study, sponsored by Histogenics Corporation.
NCT01066702 is a Phase 3 study that was terminated before completion, run by Histogenics Corporation. The registered enrollment target is 245 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (68% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01066702, a Phase 3 study, was terminated before completion, sponsored by Histogenics Corporation.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 245 participants
- Enrollment target
Study Summary
This confirmatory study is a prospective randomized trial comparing the efficacy and safety of an autologous chondrocyte tissue implant (NeoCart) to the surgical intervention microfracture in the treatment of cartilage defects in the knee.
Interventions
- PROCEDURE Microfracture
- BIOLOGICAL NeoCart
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 245 participants |
| Start Date | 2010-05 |
| Est. Completion | 2019-03 |
| Phase | Phase 3 |
Why NCT01066702 stopped before completion
NCT01066702 is an interventional study that assigns participants to a tested intervention. The registered 245 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (68% lower).
The record links to 0 conditions, and to 2 interventions - of which Microfracture is the first listed.
NCT01066702 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01066702 about?
NCT01066702 is a clinical study titled "Confirmatory Study of NeoCart in Knee Cartilage Repair". This confirmatory study is a prospective randomized trial comparing the efficacy and safety of an autologous chondrocyte tissue implant (NeoCart) to the surgical intervention microfracture in the treatment of cartilage defects in the knee.
What is the current status of trial NCT01066702?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 245 participants. The study started on 2010-05. Estimated completion is 2019-03.
What interventions are being tested in trial NCT01066702?
The interventions under investigation include: Microfracture (PROCEDURE), NeoCart (BIOLOGICAL).
Who is sponsoring clinical trial NCT01066702?
This trial is sponsored by Histogenics Corporation, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01066702's enrollment target sits among peer trials
245 1267th of 2000 higher than 732 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03645928 · 245 participants · Phase 2
Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors
- NCT04718168 · 245 participants · NA
GORE® ENFORM Biomaterial Product Study
- NCT05145127 · 245 participants · Phase 3
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
- NCT05446259 · 245 participants
Degenerative Cervical Myelopathy Repository
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia